CIK: 0001053906
Total reported value
$1.0B
Reporting period: 2026-03-31 · Number of holdings: 2
Artal Group S.A. disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $1.0B and a quarterly turnover rate of 34.3%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "A"
Artal Group S.A.'s disclosed holdings carry a Herfindahl concentration index of 0.636 — mathematically equivalent to about 2 equally-sized positions, close to its 2 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.74), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
Recent activity leans toward adding more aggressively to already-large existing positions than to newly initiated ones (a 21.9 percentage-point tilt) — a pattern consistent with a momentum-following approach.
Trim CAVA
0.0% $211.2M
Add LXRX
+13.6% $84.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CAVA | Cava Group INC | Stock-Consumer Disc | 76.11% | -1.98% | — | |
| 2 | LXRX | Lexicon Pharmaceuticals INC | Stock-Other | 23.89% | +1.98% | +13.62% |
Performance for Q3 2026
-11%
Performance Last 4 Quarters
+0.3%
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 2 | $1.0B | 34 | |
| 2025-12-31 | 2 | $714.6M | 6 | |
| 2025-09-30 | 2 | $758.2M | 100 | |
| 2025-06-30 | 2 | $930.2B | 0 | |
| 2025-03-31 | 2 | $884.2B | 100 | |
| 2024-12-31 | 2 | $1.2T | 0 | |
| 2024-09-30 | 2 | $2.4B | 0 | |
| 2024-06-30 | 114 | $3.9B | 0 | |
| 2024-03-31 | 113 | $3.9B | 0 | |
| 2023-12-31 | 98 | $3.0B | 0 | |
| 2023-09-30 | 105 | $2.3B | 0 | |
| 2023-06-30 | 119 | $3.2B | 0 | |
| 2023-03-31 | 120 | $1.7B | 0 | |
| 2022-12-31 | 131 | $1.8B | 0 | |
| 2022-09-30 | 137 | $2.3B | 0 | |
| 2022-06-30 | 137 | $1.9B | 0 | |
| 2022-03-31 | 139 | $2.4B | 0 | |
| 2021-12-31 | 152 | $3.7B | 0 | |
| 2021-09-30 | 148 | $4.5B | 0 | |
| 2021-06-30 | 146 | $4.9B | 100 | |
| 2021-03-31 | 148 | $5.7B | 56 | |
| 2020-12-31 | 132 | $4.7B | 71 | |
| 2020-09-30 | 137 | $4.1B | 69 | |
| 2020-06-30 | 134 | $3.6B | 64 | |
| 2020-03-31 | 105 | $2.4B | 64 | |
| 2019-12-31 | 99 | $2.6B | 48 | |
| 2019-09-30 | 109 | $2.5B | 81 | |
| 2019-06-30 | 109 | $2.5B | 47 | |
| 2019-03-31 | 110 | $2.4B | 53 | |
| 2018-12-31 | 108 | $2.7B | 52 | |
| 2018-09-30 | 108 | $3.8B | 49 | |
| 2018-06-30 | 106 | $4.7B | 84 | |
| 2018-03-31 | 110 | $8.0B | 39 | |
| 2017-12-31 | 121 | $6.6B | 28 | |
| 2017-09-30 | 113 | $5.8B | 37 | |
| 2017-06-30 | 110 | $5.7B | 35 | |
| 2017-03-31 | 97 | $4.5B | 26 | |
| 2016-12-31 | 93 | $4.5B | 29 | |
| 2016-09-30 | 94 | $5.1B | 34 | |
| 2016-06-30 | 70 | $4.8B | 21 | |
| 2016-03-31 | 61 | $5.1B | 44 | |
| 2015-12-31 | 81 | $5.3B | 33 | |
| 2015-09-30 | 77 | $4.5B | 86 | |
| 2015-06-30 | 71 | $2.3B | 92 | |
| 2015-03-31 | 72 | $2.2B | 65 | |
| 2014-12-31 | 86 | $2.8B | 38 | |
| 2014-09-30 | 87 | $2.7B | 44 | |
| 2014-06-30 | 87 | $2.5B | 42 | |
| 2014-03-31 | 95 | $2.8B | 53 | |
| 2013-12-31 | 84 | $2.8B | 38 | |
| 2013-09-30 | 81 | $3.1B | 40 | |
| 2013-06-30 | 104 | $3.2B | 0 |
Artal Group S.A.'s most significant position changes for 2026-03-31: Add: Lexicon Pharmaceuticals INC (LXRX) — shares +13.62%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LXRX | Lexicon Pharmaceuticals INC | +2% | +13.62% | Add |
| 2 | CAVA | Cava Group INC | -2% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-12 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-12 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-13 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-14 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-13 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-17 | Amendment | View on EDGAR |
| 2024-03-31 | 2024-05-13 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-09 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-13 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-11 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-12 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-11 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-12 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-11 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-13 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-11 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-13 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-14 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-13 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-09 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-10 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-11 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-09 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-10 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-10 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-09 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-08 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-11 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-11 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-12 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-12 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-13 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-13 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-13 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-13 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-13 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-14 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-15 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2013-11-14 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2013-08-13 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001691804
Total reported value
$1.0B
177 stks
2023-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001498900
Total reported value
$1.0B
300 stks
2016-06-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001994563
Total reported value
$1.0B
1,351 stks
2026-06-30
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001340098
Total reported value
$25.4M
1 stks
2021-03-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Lexicon Pharmaceuticals INC
CIK 0001448793
Total reported value
$891.0M
7 stks
2026-03-31
1 of the top 5 holdings overlap, including Cava Group INC
CIK 0001787596
Total reported value
$791.3M
88 stks
2026-03-31
1 of the top 5 holdings overlap, including Cava Group INC